Publikationen in Zusammenarbeit mit Forschern von Ghent University (7)

2021

  1. Frequency and prognostic impact of alk amplifications and mutations in the european neuroblastoma study group (siopen) high-risk neuroblastoma trial (hr-nbl1)

    Journal of Clinical Oncology, Vol. 39, Núm. 30, pp. 3377-3390

2020

  1. 11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in Neuroblastoma

    Cell Reports, Vol. 32, Núm. 12

2018

  1. Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients

    JCI insight, Vol. 3, Núm. 23

2016

  1. Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma

    Oncotarget, Vol. 7, Núm. 2, pp. 1960-1972

2015

  1. Facilitated Anion Transport Induces Hyperpolarization of the Cell Membrane That Triggers Differentiation and Cell Death in Cancer Stem Cells

    Journal of the American Chemical Society, Vol. 137, Núm. 50, pp. 15892-15898

2012

  1. Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers

    Genome Biology, Vol. 13, Núm. 10

2010

  1. An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours

    Oncogene, Vol. 29, Núm. 24, pp. 3583-3592